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Etiology of preeclampsia is clearly unknown. The aim of this study was to assess 
thyroid hormone levels in mild and severe preeclampsia women and compare 
them with healthy pregnant women. This study was done on 50 healthy pregnant 
and 50 preeclampsia women in the third trimester in the Sayyad Shirazi 
educational Hospital, Gynecology Department of Golestan University of Medical 
Sciences, Iran, 2014. There were significant differences in T4 level among mild 
preeclampsia and healthy pregnant women. There were also significant 
differences in T4 and T3 levels between severe, mild preeclampsia women and 
healthy pregnant women. We observed a significant positive correlation between 
systolic and diastolic blood pressure and thyroid hormones. Serum T3 and T4 
levels were significantly increased with development of preeclampsia. There is 
association between thyroid hormone abnormalities and hypertension. The 
difference of our study with other findings could be related to different 
geographical areas, races and diets. Variation of thyroid functioning later in life 
may develop in preeclampsia women. Thus, it suggests that thyroid function test 
may necessary to screen preeclampsia women during pregnancy and after 
parturition. 
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INTRODUCTION 
There are an association between preeclampsia and a 
high incidence of maternal and fetal mortality 
(Cunningham et al., 2010). Preeclampsia happens after 
20 weeks pregnancy and shows various disorders such as 
hypertension, edema and proteinuria (Pankaj et al., 2008). 
Liver, kidney and brain are the most affected organs in 
preeclampsia women (Duha and Konar, 2001). It is 
reported that preeclampsia influences 0.4-2.8% of all 
pregnancies in developed and developing  countries 
(Villar et al., 2003). The most risk of preeclampsia 
usually occurs  in women  younger than 20 years 
(Brooks, 2005). Prevalence of preeclampsia is seen more 
in developing countries.  This  can be because of 
poverty, malnutrition, micronutrient deficiencies, early 
marriage, early child birth and lack of antenatal care 
(Khatoon, 1992). Many studies indicated a relationship 
between of thyroid hormone levels and development and 
severity of preeclampsia (Raoofi et al., 2014). Etiology of 
preeclampsia is not completely clear. Studies on 
preeclampsia patients have been revealed that 16.7 and 
43.7% of subjects were sub-clinical and overt cases of 
hypothyroidism during pregnancy (Davis et al., 1988). 
There is usually an association between pregnancy and 
very mild hyperthyroxinemia. Preeclampsia women show 
high incidence of hypothyroidism that might correlate 
with the severity of preeclampsia (Lao et al., 1988, 1990; 
Kaya et al., 1994). Different studies have shown that 
mean serum TSH (thyroid-stimulating hormone) were 
significantly elevated and free T3 (triiodothyronine) and 
T4 (thyroxin) were without alterations in 
preeclampsia women (Kumar et al., 2005) whereas other 
studies showed increased level of TSH and  decreased 
levels of T3 and T4 in preeclampsia women in 
comparison with normal pregnant (Mostaghel et al., 2008; 
Kharb et al., 2013; Raoofi et al., 2014). Some 
investigators reported no change in serum TSH in 
pregnancy, while some found significant increases in TSH 
during pregnancy. Ashoor et al. (2010) showed serum 
TSH increased whereas T3 and T4 decreased with 
gestational age. Some other study showed that serum 
levels of free T4 and TSH were  increased in women 
with severe preeclampsia when compared with mild 
preeclampsia and normal pregnancy (Larijani et al., 
2004). Studies have shown that hypertensive disorders 
may cause of maternal and fetal morbidity and mortality. 
There are many other complications such as renal failure, 
disseminated intravascular coagulation, cerebrovascular 
bleeding, intrauterine growth retardation, abruption 
placenta, premature delivery and stillbirths that  may 
cause also maternal and fetal morbidity and mortality 
(Duley, 2009; Steegers et al., 2010). Some findings have 
indicated an elevated risk of hypertensive disorders in 
mothers with hypothyroidism (Ashoor et al., 2010; 
Mannisto et al., 2013; Wilson et al., 2012) or 
hyperthyroidism  (Mannisto  et  al., 2013), while some 
of other studies did not show any associations 
(Casey et al., 2005; Cleary-Goldman et al., 2008; 
Karakosta et al., 2012; Mannisto et al., 2010). Most of 
these studies did not control some factors like thyroid 
autoimmunity, smoking, Body Mass Index (BMI), 
ethnicity, socioeconomic status  and parity. Many 
studies have revealed that a small  change in function 
of thyroid can affect on  pregnancy complications 
(Medici et al., 2013; Shields et al., 2011; Taylor et al., 
2013). Some recent studies indicated that a little change 
in thyroid function can influence on complications of 
pregnancy (Medici et al., 2013; Shields et al., 2011; 
Taylor et al., 2013). It is reported that women with 
preeclampsia may show an increased risk for decreased 
thyroid functioning later in life (Levin et al., 2009). 
Therefore, the aim of this study was to assess thyroid 
hormones in mild and severe preeclampsia women and 
healthy pregnant women. 
MATERIALS AND METHODS 
This study was done on 50 healthy pregnant and 
50 preeclampsia women in the third trimester in the 
Sayyad shirazi educational Hospital, Gynecology 
Department of Golestan University of Medical Sciences, 
Iran, 2014. The study was approved by Ethical 
Committees of the Research Deputy of University of 
Medical Sciences Systolic and diastolic blood pressure 
was measured  by using a standard mercury 
manometer with women in sitting position, from their 
right hands. Definition of 1-preeclampsia (n = 50), 2-mild 
preeclampsia (n = 35) and 3-severe preeclampsia (n = 15) 
women were as follow: 
C A blood pressure higher than 130/85 mmHg and 
proteinuria with 1+or greater by dipstick 
C A blood pressure higher than 160/110 mmHg or 
proteinuria with 1+-3+by dipstick 
C A blood pressure higher than 160/110 mmHg or 
proteinuria greater than 3+by dipstick (Bolte et al., 
2001) 
Preeclampsia was diagnosed by a gynecologist. All 
three groups were age, body mass index and gravidity 
matched. Blood pressure higher than 140/90 mmHg on at 
least two occasions 6 h apart and/or proteinuria 
were inclusion criteria for preeclampsia women 
(Weinstein, 1982). Healthy pregnant group had T3 
(triiodothyronine), T4  (thyroxine) and TSH 
(thyroid-stimulating hormone) values and blood pressure 
within normal range. Our exclusion criteria were history 
of diabetes mellitus, chronic hypertension, renal, 
cardiovascular, liver disease, endocrine disorder, any 
39 
  
  
    
 
 
 
     
 
 
  
 
 
  
 
 
  
 
 
 
 
  
 
J. Med. Sci., 15 (1): 38-43, 2015 
chronic illness, twin pregnancies, preexisting thyroid 
disease, thyroid medication usage and fertility treatment. 
Ten milliliter blood sample was provided from all 
subjects. T3, T4 and TSH were measured using 
commercial kits and Elisa (Model: Statfax-2100, USA). 
The results were shown in Mean±standard deviation. 
Statistical analyze of data was carried out by SPSS-16 
version. Comparison of thyroid hormones between 
preeclampsia (mild and severe) and healthy women 
(differences between groups) was performed using 
independent sample t-test. Correlations between 
parameters were done by Pearson correlation test. 
p-value<0.05 was considered significant. 
RESULTS 
Fifty woman with the diagnosis of preeclampsia and 
50 healthy pregnant women were  taken part in this 
study. The mean age of the preeclampsia and healthy 
pregnant women were 26.54±3.74 and 26.47±4.50 years, 
respectively. 
The mean gestational age was 31.24±3.49 and 
30.17±3.10 weeks in preeclampsia  and healthy 
pregnant women.  The mean  TSH of preeclampsia 
and healthy pregnant women were 2.30±1.47 and 
1.82±1.32 µIU dLG1, respectively and there was no 
significant difference between the two groups (p = 0.097). 
The mean T4 of preeclampsia and healthy pregnant 
women were 5.03±3.04 and 5.02±2.01 µg dLG1, 
respectively and there was no significant difference 
between the two groups (p = 0.98). 
The mean T3 of preeclampsia and healthy pregnant 
women were 4.0±1.45 and 3.90±1.26 µg dLG1, 
respectively and there was no significant difference 
between the 2 groups (p = 0.74) (Table 1). No significant 
differences were considered in TSH and T3 levels among 
mild preeclampsia and healthy pregnant women but there 
were significant differences in T4 level (p = 0.005). 
There are significant differences in T4 and T3 levels 
when severe, mild preeclampsia women and healthy 
pregnant women with each other (Table 2). Correlations 
between thyroid hormones and systolic and diastolic 
blood pressure are shown in Table 3. We observed a 
significant positive correlation between systolic and 
diastolic blood pressure and thyroid hormones. There 
were no correlations between TSH and systolic blood 
pressure. 
DISCUSSION 
Different factors may play an important role in 
development of preeclampsia. Etiology of preeclampsia 
is clearly unknown and it may happen at second or third 
trimester  of pregnancy (Mehdi  et  al., 2009; 
Hasanzadeh et al., 2008). Some studies showed an 
association between the levels of thyroid hormones and 
development of preeclampsia. In present study, our 
findings showed that levels of TSH and T3 were higher in 
preeclampsia women and no changes in the level of T4 in 
preeclampsia women compared to healthy pregnant 
women (p>0.05) which was not in agreement with the 
finding of other study (Kumar et al., 2005; Lao et al., 
1990; Skjoldebrand et al., 1986; Basbug et al., 1999). 
Several studies showed that there are a significant 
association between thyroid hormones and the 
development    and  severity of preeclampsia 
(Ipadeola et al., 2013; Osathanondh  et  al., 1976; 
Raoofi et al., 2014; Kumar et al., 2005). Various other 
studies with different findings are available with relation 
to T4 (Low and high levels of  T4) and TSH levels 
(High levels  of TSH) in preeclampsia  women 
(Kumar et al., 2005; Tolino et al., 1985; Raoofi et al., 
2014). Some studies have shown that there were no 
significant differences in TSH levels between 
preeclampsia and healthy women which is in agreement 
with our results (Qublan et al., 2003; Khaliq et al., 1999). 
In the present study, T4 level was significantly lower in 
mild preeclamptics when compared with healthy pregnant 
women (p<0.05), who are in agreement with findings of 
other studies (Qublan et al., 2003; Levin et al., 2009). 
Severe preeclampsia women showed significantly higher 
T4 and T3 levels compared to healthy ones (p = 0.0001 
and p = 0.001). Qublan et al. (2003) showed that the 
thyroid function is not changed in severe preeclampsia. 
The increased level of TSH (not significant) in 
preeclampsia women shows an association with the risk 
for developing and severity  of preeclampsia 
(Mostaghel et al., 2008). Many studies indicated that 
preeclampsia women showed significantly increased or no 
significant elevation level of TSH (Khaliq et al., 1999; 
Sardana et al., 2009). This alteration may occur as a result 
of association of increased level of TSH with thyroid 
peroxidase antibodies (Kaya et al., 1994). Thyroid 
dysfunction may change thyroid hormone secretion which 
can significantly increase T3 and T4 levels in severe 
Table 1: Clinical and biochemical characteristic of preeclampsia and healthy pregnant women 
Parameters Women with preeclampsia Healthy pregnant women p-value 
No. (%) 50.00 50.00 
Maternal age (years) 26.50±3.90 27.10±4.60 0.449 
Gestational age (weeks) 31.24±3.49 30.17±3.10 0.355 
Hypertensive (%) 100.00 - ­
TSH (µIU dLG1) 2.30±1.47 1.82±1.32 0.097 
T4 (µg dLG1) 5.03±3.04 5.02±2.01 0.980 
T3 (µg dLG1) 4.00±1.45 3.90±1.26 0.740 
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Table 2: Clinical and biochemical characteristic of women with mild and severe preeclampsia and healthy pregnant women 
Women 
with mild 
Healthy 
pregnant 
Women 
with severe 
Healthy 
pregnant 
Women 
with severe 
Women 
with mild 
Parameters preeclampsia women p-value preeclampsia women p-value preeclampsia preeclampsia p-value 
No. (%) 35.00 (70) 50 15.00 (30) 50 15.00 (30) 35.00 (70) 
Maternal age (years) 
Gestational age (weeks) 
TSH (µ IU dLG1) 
T4 (µg dLG1) 
T3 (µg dLG1) 
27.00±4.11 
31.47±3.66 
2.30±1.50 
3.57±2.07 
3.46±1.20 
27.10±4.60 
30.17±3.10 
1.82±1.30 
5.02±2.01 
3.90±1.26 
0.843 
0.848 
0.271 
0.005 
0.227 
25.41±3.50 
28.75±8.69 
2.27±1.37 
8.44±2.06 
5.25±1.21 
27.10±4.60 
30.17±3.10 
1.82±1.30 
5.02±2.01 
3.90±1.26 
0.369 
0.813 
0.539 
0.0001 
0.001 
25.41±3.50 
28.75±8.69 
2.27±1.37 
8.44±2.06 
5.25±1.21 
27.00±4.11 
31.47±3.66 
2.30±1.50 
3.57±2.07 
3.46±1.20 
0.434 
0.892 
0.435 
0.0001 
0.0001 
Table 3: Correlation of thyroid hormones with systolic and diastolic and in the pathophysiology of hypertensive disorders during
blood pressure pregnancy (Steegers et al., 2010). Developed prediction Parameters TSH T4 T3 model suggested by Poon et al. (2009). The model Systolic blood pressure R = 0.174 P = 0.084 R = 0.216 
P = 0.031 R = 0.198 P = 0.048 contains maternal history, uterine artery pulsatility index; 
Diastolic blood pressure R = 0.206 P = 0.039 R = 0.296 mean arterial pressure, pregnancy-associated plasma 
P = 0.003 R = 0.205 P = 0.041 protein-A and placental growth factor (Poon et al., 2009). 
It can suggest that the use of thyroid function test is 
preeclampsia women. These findings were inconsistent practical for diagnose of thyroid function.
with some  other studies (Kumar et al., 2005; 
Pasupathi et al., 2009; Casey et al., 2005). A study has CONCLUSION
indicated that there are a correlation between alterations 
in thyroid hormone levels and occurrence and severity of The results of the present study suggest that there 
morbidity and mortality of preeclampsia women. It has were no significant different in T3, T4 and TSH levels 
shown that TSH levels of 5 µ IU mLG1 cause to a higher between preeclampsia and healthy pregnant women, but 
risk of development of preeclampsia (Qublan et al., serum T3 and T4 levels were significantly increased with 
2003). Severe preeclampsia women showed development of preeclampsia. There is association 
significantly higher T4 and T3 levels compared to mild between thyroid abnormalities and pregnancy caused 
ones (p = 0.0001 and p = 0.0001). This means that with hypertension. The difference of our study with other 
development of preeclampsia from mild to severe, thyroid findings could be related to different geographical areas, 
dysfunction may occur in preeclampsia women. This may races and diets. Variation of thyroid functioning later in 
cause by pathological alterations and unusual secretion of life may develop in preeclampsia women. Thus, it
 
thyroid tissue that may influence on T3 and T4 synthesis suggests that thyroid function test may necessary to
 
and secretion. The mechanism of thyroid hormone screen preeclampsia women during pregnancy and after
 
alterations is not exactly clear in preeclampsia women. parturition.
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